Derrell Porter

Company: CTRL Therapeutics New!

Job title: CEO

Seminars:

Circulating Tumor Reactive T-Cells (cTRLs) – Characteristics & Novel Approach to Isolation 11:30 am

Utilizing IsoQore technology for effective isolation of cTRLs from blood as a means of non-invasive sample collection Key characteristics and advantages of cTRLs Read more

day: Conference Day Two - Track B - AM